Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Sarcopenia | Research article

Sarcopenia is associated with non-motor symptoms in Han Chinese patients with Parkinson's Disease: a cross-sectional study

Authors: Qiu-Wan Liu, Cheng-Jie Mao, Zhao-Hui Lu, Rong-Fang Shi, Ying-Chun Zhang, Ping Zhao, Chun-Feng Liu

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Sarcopenia is commonly seen in the older adults and increases in incidence with age, also in Parkinson’s disease (PD). Although research has indicated that the development of sarcopenia in patients with PD may be related to both motor symptoms and non-motor symptoms (NMS), the precise relationship between the two conditions remains unclear. Therefore, we aimed to investigate the incidence of sarcopenia in patients with PD and its association with NMS.

Methods

The study included 123 patients with PD and 38 age- and sex-matched healthy controls (HC). All participants were evaluated for sarcopenia using the 2019 Asian Sarcopenia Diagnostic Criteria, and patients with PD underwent standard assessments of motor symptoms and NMS. Multiple logistic regression and receiver operating characteristic (ROC) curve analyses were used to examine the association between sarcopenia and NMS in patients with PD.

Results

The incidence of sarcopenia was significantly higher in patients with PD than in HC (26.8% vs. 10.4%, p = 0.046). Multiple logistic regression analysis revealed that poorer sleep quality (odds ratio [OR]: 1.245; 95% confidence interval [CI]: 1.011–1.533; p = 0.040) and fatigue (OR: 1.085, 95% CI: 1.006–1.170, p = 0.034) were independently associated with sarcopenia. ROC analysis indicated that the optimal cut-off value for Pittsburgh Sleep Quality Index (PSQI) scores was 10, with 72.7% sensitivity and 74.4% specificity (area under the curve [AUC] = 0.776, 95% CI: 0.683–0.868, p < 0.001). The optimal cut-off value for Fatigue Severity Scale (FSS) scores was 39, with 87% sensitivity and 50% specificity (AUC = 0.725, 95% CI: 0.629 –0.820, p < 0.001). Joint use of FSS and PSQI scores increased the predictive value for sarcopenia(AUC = 0.804, 95% CI: 0.724–0.885, p < 0.001).

Conclusion

Patients with PD are more susceptible to sarcopenia than healthy older adults, and fatigue and poorer sleep are positively associated with sarcopenia. Further longitudinal studies are needed to clarify the causal relationships.
Literature
1.
go back to reference Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;17:939–53.CrossRef Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;17:939–53.CrossRef
2.
3.
go back to reference Martinez-Martin P. The importance of non-motor disturbances to quality of life in Parkinson’s disease. J Neurol Sci. 2011;310:12–6.CrossRefPubMed Martinez-Martin P. The importance of non-motor disturbances to quality of life in Parkinson’s disease. J Neurol Sci. 2011;310:12–6.CrossRefPubMed
4.
go back to reference Martinez-Martin P. Nonmotor symptoms and health-related quality of life in early Parkinson’s disease: nonmotor symptoms and HRQOL IN PD. Mov Disord. 2014;29:166–8.CrossRefPubMed Martinez-Martin P. Nonmotor symptoms and health-related quality of life in early Parkinson’s disease: nonmotor symptoms and HRQOL IN PD. Mov Disord. 2014;29:166–8.CrossRefPubMed
5.
go back to reference Angulo J, El Assar M, Rodríguez-Mañas L. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med. 2016;50:1–32.CrossRefPubMed Angulo J, El Assar M, Rodríguez-Mañas L. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med. 2016;50:1–32.CrossRefPubMed
6.
go back to reference Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015;47:1801–7.CrossRefPubMed Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015;47:1801–7.CrossRefPubMed
8.
go back to reference Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CMM, Bain VG, Beaumont C, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 2013;47:861–70.CrossRefPubMed Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CMM, Bain VG, Beaumont C, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 2013;47:861–70.CrossRefPubMed
9.
go back to reference Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, et al. Prevalence and associated factors of sarcopenia and frailty in Parkinson’s Disease: a cross-sectional study. Gerontology. 2019;65:216–28.CrossRefPubMed Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, et al. Prevalence and associated factors of sarcopenia and frailty in Parkinson’s Disease: a cross-sectional study. Gerontology. 2019;65:216–28.CrossRefPubMed
11.
go back to reference Lim S, Kwon S-Y, Yoon JW, Kim SY, Choi SH, Park YJ, et al. Association between body composition and pulmonary function in elderly people: the Korean longitudinal study on health and aging. Obesity. 2011;19:631–8.CrossRefPubMed Lim S, Kwon S-Y, Yoon JW, Kim SY, Choi SH, Park YJ, et al. Association between body composition and pulmonary function in elderly people: the Korean longitudinal study on health and aging. Obesity. 2011;19:631–8.CrossRefPubMed
12.
go back to reference Sarodnik C, Bours SPG, Schaper NC, van den Bergh JP, van Geel TACM. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018;109:70–7.CrossRefPubMed Sarodnik C, Bours SPG, Schaper NC, van den Bergh JP, van Geel TACM. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018;109:70–7.CrossRefPubMed
13.
go back to reference Tang T-C, Hwang A-C, Liu L-K, Lee W-J, Chen L-Y, Wu Y-H, et al. FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-lan longitudinal aging study. The Journals of Gerontology: Series A. 2018;73:828–34. Tang T-C, Hwang A-C, Liu L-K, Lee W-J, Chen L-Y, Wu Y-H, et al. FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-lan longitudinal aging study. The Journals of Gerontology: Series A. 2018;73:828–34.
14.
go back to reference Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, Onder G, Brandi V, et al. Sarcopenia in Parkinson Disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc. 2018;19:523–7.CrossRefPubMed Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, Onder G, Brandi V, et al. Sarcopenia in Parkinson Disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc. 2018;19:523–7.CrossRefPubMed
15.
go back to reference Lima DP, de Almeida SB, Bonfadini J de C, de Luna JRG, de Alencar MS, Pinheiro-Neto EB, et al. Clinical correlates of sarcopenia and falls in Parkinson’s disease. PLoS ONE. 2020;15:e0227238. Lima DP, de Almeida SB, Bonfadini J de C, de Luna JRG, de Alencar MS, Pinheiro-Neto EB, et al. Clinical correlates of sarcopenia and falls in Parkinson’s disease. PLoS ONE. 2020;15:e0227238.
16.
go back to reference Drey M, Hasmann SE, Krenovsky J-P, Hobert MA, Straub S, Elshehabi M, et al. Associations between early markers of Parkinson’s Disease and sarcopenia. Front Aging Neurosci. 2017;9:53.CrossRefPubMedPubMedCentral Drey M, Hasmann SE, Krenovsky J-P, Hobert MA, Straub S, Elshehabi M, et al. Associations between early markers of Parkinson’s Disease and sarcopenia. Front Aging Neurosci. 2017;9:53.CrossRefPubMedPubMedCentral
17.
go back to reference Lee C-Y, Chen H-L, Chen P-C, Chen Y-S, Chiang P-L, Wang C-K, et al. Correlation between executive network integrity and sarcopenia in patients with Parkinson’s Disease. IJERPH. 2019;16:4884.CrossRefPubMedPubMedCentral Lee C-Y, Chen H-L, Chen P-C, Chen Y-S, Chiang P-L, Wang C-K, et al. Correlation between executive network integrity and sarcopenia in patients with Parkinson’s Disease. IJERPH. 2019;16:4884.CrossRefPubMedPubMedCentral
18.
go back to reference Cai Y, Feng F, Wei Q, Jiang Z, Ou R, Shang H. Sarcopenia in patients with Parkinson’s Disease: a systematic review and meta-analysis. Front Neurol. 2021;12: 598035.CrossRefPubMedPubMedCentral Cai Y, Feng F, Wei Q, Jiang Z, Ou R, Shang H. Sarcopenia in patients with Parkinson’s Disease: a systematic review and meta-analysis. Front Neurol. 2021;12: 598035.CrossRefPubMedPubMedCentral
19.
go back to reference Tan AH, Hew YC, Lim S-Y, Ramli NM, Kamaruzzaman SB, Tan MP, et al. Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson’s disease. Parkinsonism Relat Disord. 2018;56:58–64.CrossRefPubMed Tan AH, Hew YC, Lim S-Y, Ramli NM, Kamaruzzaman SB, Tan MP, et al. Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson’s disease. Parkinsonism Relat Disord. 2018;56:58–64.CrossRefPubMed
20.
go back to reference Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307.e2.CrossRefPubMed Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307.e2.CrossRefPubMed
21.
go back to reference Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome: Current Opinion in Clinical Nutrition and Metabolic Care. 2010;13:1–7.PubMed Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome: Current Opinion in Clinical Nutrition and Metabolic Care. 2010;13:1–7.PubMed
23.
go back to reference Welle S. Cellular and molecular basis of age-related sarcopenia. Can J Appl Physiol. 2002;27:19–41.CrossRefPubMed Welle S. Cellular and molecular basis of age-related sarcopenia. Can J Appl Physiol. 2002;27:19–41.CrossRefPubMed
24.
go back to reference Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (Sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–96.CrossRefPubMed Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (Sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–96.CrossRefPubMed
25.
go back to reference Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60.CrossRefPubMed Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60.CrossRefPubMed
26.
go back to reference Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31:652–8.CrossRefPubMed Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31:652–8.CrossRefPubMed
27.
go back to reference Yazar T, Yazar HO, Zayimoğlu E, Çankaya S. Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson’s disease. Neurol Sci. 2018;39:1415–21.CrossRefPubMed Yazar T, Yazar HO, Zayimoğlu E, Çankaya S. Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson’s disease. Neurol Sci. 2018;39:1415–21.CrossRefPubMed
28.
go back to reference Huang C-Y, Hwang A-C, Liu L-K, Lee W-J, Chen L-Y, Peng L-N, et al. Association of dynapenia, sarcopenia, and cognitive impairment among community-dwelling older Taiwanese. Rejuvenation Res. 2016;19:71–8.CrossRefPubMed Huang C-Y, Hwang A-C, Liu L-K, Lee W-J, Chen L-Y, Peng L-N, et al. Association of dynapenia, sarcopenia, and cognitive impairment among community-dwelling older Taiwanese. Rejuvenation Res. 2016;19:71–8.CrossRefPubMed
29.
go back to reference Scalzo P, Kümmer A, Cardoso F, Teixeira AL. Serum levels of interleukin-6 are elevated in patients with Parkinson’s disease and correlate with physical performance. Neurosci Lett. 2010;468:56–8.CrossRefPubMed Scalzo P, Kümmer A, Cardoso F, Teixeira AL. Serum levels of interleukin-6 are elevated in patients with Parkinson’s disease and correlate with physical performance. Neurosci Lett. 2010;468:56–8.CrossRefPubMed
30.
31.
go back to reference Pereira LSM, Narciso FMS, Oliveira DMG, Coelho FM, Souza D da G de, Dias RC. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Archives of Gerontology and Geriatrics. 2009;48:313–6. Pereira LSM, Narciso FMS, Oliveira DMG, Coelho FM, Souza D da G de, Dias RC. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Archives of Gerontology and Geriatrics. 2009;48:313–6.
32.
go back to reference Cesari M, Penninx BWJH, Pahor M, Lauretani F, Corsi AM, Williams GR, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:M242–8.CrossRef Cesari M, Penninx BWJH, Pahor M, Lauretani F, Corsi AM, Williams GR, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:M242–8.CrossRef
33.
go back to reference Wu Y-N, Chen M-H, Chiang P-L, Lu C-H, Chen H-L, Yu C-C, et al. Associations between brain structural damage and core muscle loss in patients with Parkinson’s Disease. JCM. 2020;9:239.CrossRefPubMedPubMedCentral Wu Y-N, Chen M-H, Chiang P-L, Lu C-H, Chen H-L, Yu C-C, et al. Associations between brain structural damage and core muscle loss in patients with Parkinson’s Disease. JCM. 2020;9:239.CrossRefPubMedPubMedCentral
34.
go back to reference Caviness JN, Smith BE, Clarke Stevens J, Adler CH, Caselli RJ, Hentz JG, et al. Motor unit number estimates in idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2002;8:161–4.CrossRefPubMed Caviness JN, Smith BE, Clarke Stevens J, Adler CH, Caselli RJ, Hentz JG, et al. Motor unit number estimates in idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2002;8:161–4.CrossRefPubMed
35.
go back to reference Drey M, Krieger B, Sieber CC, Bauer JM, Hettwer S, Bertsch T, et al. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc. 2014;15:435–9.CrossRefPubMed Drey M, Krieger B, Sieber CC, Bauer JM, Hettwer S, Bertsch T, et al. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc. 2014;15:435–9.CrossRefPubMed
36.
go back to reference Basualto-AlarcÃ3n C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and Androgens: A Link between Pathology and Treatment. Front Endocrinol. 2014;5. Basualto-AlarcÃ3n C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and Androgens: A Link between Pathology and Treatment. Front Endocrinol. 2014;5.
37.
go back to reference Adams F, Boschmann M, Lobsien E, Kupsch A, Lipp A, Franke G, et al. Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease. Eur J Clin Pharmacol. 2008;64:863–70.CrossRefPubMed Adams F, Boschmann M, Lobsien E, Kupsch A, Lipp A, Franke G, et al. Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease. Eur J Clin Pharmacol. 2008;64:863–70.CrossRefPubMed
38.
go back to reference Liu C-F, Wang T, Zhan S-Q, Geng D-Q, Wang J, Liu J, et al. Management recommendations on sleep disturbance of patients with Parkinson’s Disease. Chin Med J. 2018;131:2976–85.CrossRefPubMedPubMedCentral Liu C-F, Wang T, Zhan S-Q, Geng D-Q, Wang J, Liu J, et al. Management recommendations on sleep disturbance of patients with Parkinson’s Disease. Chin Med J. 2018;131:2976–85.CrossRefPubMedPubMedCentral
39.
go back to reference Falup-Pecurariu C, Diaconu Ş. Sleep Dysfunction in Parkinson’s Disease. In: International Review of Neurobiology. Elsevier; 2017. p. 719–42. Falup-Pecurariu C, Diaconu Ş. Sleep Dysfunction in Parkinson’s Disease. In: International Review of Neurobiology. Elsevier; 2017. p. 719–42.
40.
go back to reference Piovezan RD, Abucham J, dos Santos RVT, Mello MT, Tufik S, Poyares D. The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing Res Rev. 2015;23:210–20.CrossRefPubMed Piovezan RD, Abucham J, dos Santos RVT, Mello MT, Tufik S, Poyares D. The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing Res Rev. 2015;23:210–20.CrossRefPubMed
42.
go back to reference Grace J, Mendelsohn A, Friedman JH. A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat Disord. 2007;13:443–5.CrossRefPubMed Grace J, Mendelsohn A, Friedman JH. A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat Disord. 2007;13:443–5.CrossRefPubMed
43.
go back to reference Wang B, Thapa S, Zhou T, Liu H, Li L, Peng G, et al. Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer. 2020;28:581–8.CrossRefPubMed Wang B, Thapa S, Zhou T, Liu H, Li L, Peng G, et al. Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer. 2020;28:581–8.CrossRefPubMed
44.
go back to reference Kara M, Kaymak B, Frontera W, Ata A, Ricci V, Ekiz T, et al. Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM. J Rehabil Med. 2021;53:jrm00209.CrossRefPubMed Kara M, Kaymak B, Frontera W, Ata A, Ricci V, Ekiz T, et al. Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM. J Rehabil Med. 2021;53:jrm00209.CrossRefPubMed
45.
go back to reference Kara M, Kaymak B, Ata AM, Özkal Ö, Kara Ö, Baki A, et al. STAR—Sonographic Thigh Adjustment Ratio: a golden formula for the diagnosis of sarcopenia. Am J Phys Med Rehabil. 2020;99:902–8.CrossRefPubMed Kara M, Kaymak B, Ata AM, Özkal Ö, Kara Ö, Baki A, et al. STAR—Sonographic Thigh Adjustment Ratio: a golden formula for the diagnosis of sarcopenia. Am J Phys Med Rehabil. 2020;99:902–8.CrossRefPubMed
46.
go back to reference Tsukasaki K, Matsui Y, Arai H, Harada A, Tomida M, Takemura M, et al. Association of muscle strength and gait speed with cross-sectional muscle area determined by mid-thigh computed tomography – a comparison with skeletal muscle mass measured by dual-energy x-ray absorptiometry. J Frailty Aging. 2020;:1–8. Tsukasaki K, Matsui Y, Arai H, Harada A, Tomida M, Takemura M, et al. Association of muscle strength and gait speed with cross-sectional muscle area determined by mid-thigh computed tomography – a comparison with skeletal muscle mass measured by dual-energy x-ray absorptiometry. J Frailty Aging. 2020;:1–8.
Metadata
Title
Sarcopenia is associated with non-motor symptoms in Han Chinese patients with Parkinson's Disease: a cross-sectional study
Authors
Qiu-Wan Liu
Cheng-Jie Mao
Zhao-Hui Lu
Rong-Fang Shi
Ying-Chun Zhang
Ping Zhao
Chun-Feng Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04188-3

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine